by Bay Biosciences | Oct 28, 2022 | News Releases
Bay Biosciences provides high quality, clinical grade, FFPE tissue block samples with matched K2EDTA plasma, sera (serum) and peripheral blood mononuclear cells (PBMC) biofluid samples from invasive ductal carcinoma (IDC) breast cancer patients. The K2EDTA plasma,...
by Bay Biosciences | Oct 23, 2022 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved skeletal muscle biopsy tissue samples with matched K2EDTA plasma, sera (serum) and peripheral blood mononuclear cells (PBMC) biofluid samples from Becker muscular dystrophy (BMD) patients....
by Bay Biosciences | Oct 18, 2022 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved skeletal muscle biopsy tissue samples with matched K2EDTA plasma, sera (serum) and peripheral blood mononuclear cells (PBMC) biofluid samples from Duchenne muscular dystrophy patients. The...
by Bay Biosciences | Oct 6, 2022 | News Releases
Bay Biosciences provides high quality, clinical grade, cryogenically preserved matched K2EDTA plasma, sera (serum) and peripheral blood mononuclear cells (PBMC) biofluid samples from idiopathic pulmonary fibrosis (IPF) patients. The K2EDTA plasma,...
by Bay Biosciences | Sep 28, 2022 | News Releases
Bay Biosciences provides high quality, clinical grade tissue samples, FFPE Blocks with matched cryogenically preserved K2EDTA plasma, sera (serum) and peripheral blood mononuclear cells (PBMC) biofluid samples from cholangiocarcinoma patients. The K2EDTA plasma,...
by Bay Biosciences | Sep 27, 2022 | News Releases
Bay Biosciences provides high quality, clinical grade tissue samples, FFPE Blocks with matched cryogenically preserved matched K2EDTA plasma, sera (serum) and peripheral blood mononuclear cells (PBMC) biofluid samples from renal fibrosis patients. The K2EDTA plasma,...
